{
  "analysis": "kegg_pathway_knn",
  "description": "Inductive kNN using KEGG pathway Jaccard similarity",
  "purpose": "Fair comparison to TxGNN (both inductive)",
  "params": {
    "k": 20,
    "seeds": [
      42,
      123,
      456,
      789,
      1024
    ]
  },
  "data": {
    "kegg_diseases": 3454,
    "gt_diseases": 472,
    "overlap": 374,
    "coverage_pct": 79.23728813559322,
    "mean_pathways_per_disease": 47.42472495657209
  },
  "results": {
    "kegg_knn_all": {
      "mean": 0.13932711601868714,
      "std": 0.030941526242062915,
      "values": [
        0.19765494137353434,
        0.11185308848080133,
        0.13562091503267973,
        0.11462450592885376,
        0.13688212927756654
      ]
    },
    "kegg_knn_subset": {
      "mean": 0.1573452680405614,
      "std": 0.018243624237648727,
      "values": [
        0.13221884498480244,
        0.18266978922716628,
        0.17333333333333334,
        0.15081206496519722,
        0.1476923076923077
      ]
    }
  },
  "comparisons": {
    "vs_node2vec_honest": -0.1032547319594386,
    "vs_txgnn": 0.012345268040561408,
    "vs_hpo_h19": 0.01534526804056141
  },
  "interpretation": "COMPETITIVE: 15.7% R@30 is on par with TxGNN's 14.5% inductive performance. KEGG pathways provide meaningful disease similarity for drug repurposing.",
  "status": "competitive"
}